Higher BRG1 expression leads to reduction of overall survival (Figure 2A, Overall Survival, P < 0.001) and earlier tumor occurrence after surgery (Figure 2B, Disease-free Survival, P = 0.001). This evidence concerns the gene SMARCA4 and neoplasm.